Nigerian journal of clinical practice · 2025
Association of Matrix Metalloprotease 1 and 9 Promoter Polymorphisms with Obstructive Sleep Apnea: A Case-Control Study from Turkey.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Kocak M, Avcikurt A S, Sarioglu N, Erel F, Angin M, Altinisik J
Аннотация
BACKGROUND: Obstructive sleep apnea (OSA) is a sleep-related breathing disorder, and genetic factors play a role in its development. Matrix metalloproteinases (MMPs) degrade the extracellular matrix, but the role of MMP-1 and MMP-9 promoter polymorphisms in the development of OSA is not yet clear.
AIM: To investigate the relationship between MMP1 (rs1799750) -1607 1G/2G and MMP9 (rs3918242) -1562 C/T changes in OSA.
METHODS AND MATERIALS: This study includes 85 OSA patients and 97 healthy controls. Genotyping for MMP-1 (-1607) G/2G and MMP-9 (-1562) C/T was performed using Polymerase Chain Reaction Restriction Fragment Length Polymorphism (PCR-RFLP). Statistical significance was defined as P values less than 0.05.
RESULTS: This study examined 85 OSA patients and 97 healthy controls. No significant difference was found between OSA patients (47 males, 38 females, mean age: 43.85 ± 10.09) and the control group (51 males and 46 females, mean age: 43.57 ± 9.61) in terms of age and gender (P = 0.847 and P = 0.767). However, body mass index (BMI) was significantly higher in OSA patients (P < 0.001). A statistically significant difference was detected in association with the MMP1-1607 G/2G and 2G/2G genotypes and OSA compared to the G/G genotype (P = 0.013). MMP9-1562 C/T polymorphism showed no significant association with OSA, either at the genotypic level or when the C/T and T/T genotypes were combined (P > 0.05) when evaluated individually.
CONCLUSION: The MMP-1-1607 2G/G and 2G/2G genotypes are significant risk factors for OSA, while the MMP-9 - 1562 C/T polymorphism is not.
AIM: To investigate the relationship between MMP1 (rs1799750) -1607 1G/2G and MMP9 (rs3918242) -1562 C/T changes in OSA.
METHODS AND MATERIALS: This study includes 85 OSA patients and 97 healthy controls. Genotyping for MMP-1 (-1607) G/2G and MMP-9 (-1562) C/T was performed using Polymerase Chain Reaction Restriction Fragment Length Polymorphism (PCR-RFLP). Statistical significance was defined as P values less than 0.05.
RESULTS: This study examined 85 OSA patients and 97 healthy controls. No significant difference was found between OSA patients (47 males, 38 females, mean age: 43.85 ± 10.09) and the control group (51 males and 46 females, mean age: 43.57 ± 9.61) in terms of age and gender (P = 0.847 and P = 0.767). However, body mass index (BMI) was significantly higher in OSA patients (P < 0.001). A statistically significant difference was detected in association with the MMP1-1607 G/2G and 2G/2G genotypes and OSA compared to the G/G genotype (P = 0.013). MMP9-1562 C/T polymorphism showed no significant association with OSA, either at the genotypic level or when the C/T and T/T genotypes were combined (P > 0.05) when evaluated individually.
CONCLUSION: The MMP-1-1607 2G/G and 2G/2G genotypes are significant risk factors for OSA, while the MMP-9 - 1562 C/T polymorphism is not.